The interprotein scoring noises in glide docking scores
暂无分享,去创建一个
Xin Chen | Yi Fan | Wei Wang | Yuzong Chen | Xi Zhou | Wanlin He | Xiaoping Zhou | Yuzong Chen | Wei Wang | Yi Fan | Xin Chen | Wanlin He
[1] G. V. Paolini,et al. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes , 1997, J. Comput. Aided Mol. Des..
[2] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[3] Darren R. Flower,et al. On the Properties of Bit String-Based Measures of Chemical Similarity , 1998, J. Chem. Inf. Comput. Sci..
[4] J Henkel,et al. Attacking AIDS with a 'cocktail' therapy? , 1999, FDA consumer.
[5] Dana Ron,et al. Algorithmic Stability and Sanity-Check Bounds for Leave-One-Out Cross-Validation , 1997, Neural Computation.
[6] Thomas Lengauer,et al. Evaluation of the FLEXX incremental construction algorithm for protein–ligand docking , 1999, Proteins.
[7] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[8] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[9] Byron L. Lam,et al. Acute effects of sildenafil (viagra) on blue-on-yellow and white-on-white Humphrey perimetry. , 2001 .
[10] Y. Z. Chen,et al. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. , 2001, Journal of molecular graphics & modelling.
[11] Yuan-Ping Pang,et al. EUDOC: a computer program for identification of drug interaction sites in macromolecules and drug leads from chemical databases , 2001, J. Comput. Chem..
[12] R. Friesner,et al. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .
[13] Robin Taylor,et al. A new test set for validating predictions of protein–ligand interaction , 2002, Proteins.
[14] Marcel L. Verdonk,et al. The consequences of translational and rotational entropy lost by small molecules on binding to proteins , 2002, J. Comput. Aided Mol. Des..
[15] Didier Rognan,et al. ConsDock: A new program for the consensus analysis of protein–ligand interactions , 2002, Proteins.
[16] C. Ung,et al. Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients? , 2003, Natural product reports.
[17] Alexander D. MacKerell,et al. Consideration of Molecular Weight during Compound Selection in Virtual Target-Based Database Screening , 2003, J. Chem. Inf. Comput. Sci..
[18] Gerhard Klebe,et al. Relibase: design and development of a database for comprehensive analysis of protein-ligand interactions. , 2003, Journal of molecular biology.
[19] J. Lehár,et al. Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] Tianhan Xue,et al. Studying Traditional Chinese Medicine , 2003, Science.
[21] Innovation OR Stagnation. Challenge and Opportunity on the Critical Path to New Medical Products , 2004 .
[22] Shiladitya Sengupta,et al. Modulating Angiogenesis: The Yin and the Yang in Ginseng , 2004, Circulation.
[23] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[24] Renxiao Wang,et al. The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. , 2004, Journal of medicinal chemistry.
[25] J. Bajorath,et al. Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.
[26] N. Paul,et al. Recovering the true targets of specific ligands by virtual screening of the protein data bank , 2004, Proteins.
[27] Ayalew Tefferi,et al. Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders. , 2004, Blood.
[28] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[29] B. Roux,et al. Calculation of absolute protein-ligand binding free energy from computer simulations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] Joanna Owens. Screening: Dirty drugs' secrets uncovered , 2006, Nature Reviews Drug Discovery.
[31] Fujio Kasumi,et al. Efficacy and safety of combined trastuzumab and paclitaxel therapy as a second-line treatment in women with metastatic Breast Cancer: A single institutional experience , 2006, Breast cancer.
[32] Egon L. Willighagen,et al. The Blue Obelisk—Interoperability in Chemical Informatics , 2006, J. Chem. Inf. Model..
[33] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[34] Didier Rognan,et al. sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank , 2006, J. Chem. Inf. Model..
[35] Didier Rognan,et al. In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors. , 2006, Journal of medicinal chemistry.
[36] Matthew P. Repasky,et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.
[37] Jian Zhang,et al. Peptide deformylase is a potential target for anti‐Helicobacter pylori drugs: Reverse docking, enzymatic assay, and X‐ray crystallography validation , 2006, Protein science : a publication of the Protein Society.
[38] Kenichi Sugihara,et al. Effect of Combined Therapy With Low-Dose 5-Aza-2′-Deoxycytidine and Irinotecan on Colon Cancer Cell Line HCT-15 , 2007, Annals of Surgical Oncology.
[39] Jin Li,et al. On Evaluating Molecular-Docking Methods for Pose Prediction and Enrichment Factors , 2006, J. Chem. Inf. Model..
[40] Didier Rognan,et al. Development and virtual screening of target libraries , 2006, Journal of Physiology-Paris.
[41] J. Lamerdin,et al. Identifying off-target effects and hidden phenotypes of drugs in human cells , 2006, Nature chemical biology.
[42] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[43] Xiaomin Luo,et al. TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..
[44] Anders Karlén,et al. Ligand Bias of Scoring Functions in Structure-Based Virtual Screening , 2006, J. Chem. Inf. Model..
[45] Xin Wen,et al. BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..
[46] L. Meijer,et al. Inverse in silico screening for identification of kinase inhibitor targets. , 2007, Chemistry & biology.
[47] M. Gilson,et al. Calculation of protein-ligand binding affinities. , 2007, Annual review of biophysics and biomolecular structure.
[48] Tom Halgren,et al. New Method for Fast and Accurate Binding‐site Identification and Analysis , 2007, Chemical biology & drug design.
[49] David G. Lloyd,et al. Unbiasing Scoring Functions: A New Normalization and Rescoring Strategy , 2007, J. Chem. Inf. Model..
[50] M. Gilson,et al. Ligand configurational entropy and protein binding , 2007, Proceedings of the National Academy of Sciences.
[51] Paul N. Mortenson,et al. Diverse, high-quality test set for the validation of protein-ligand docking performance. , 2007, Journal of medicinal chemistry.
[52] Didier Rognan,et al. Ranking Targets in Structure-Based Virtual Screening of Three-Dimensional Protein Libraries: Methods and Problems , 2008, J. Chem. Inf. Model..
[53] 石黒 めぐみ,et al. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15 , 2008 .
[54] Christopher R. Corbeil,et al. Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go , 2008, British journal of pharmacology.
[55] Zhihai Liu,et al. Comparative Assessment of Scoring Functions on a Diverse Test Set , 2009, J. Chem. Inf. Model..
[56] Obdulia Rabal,et al. APIF: A New Interaction Fingerprint Based on Atom Pairs and Its Application to Virtual Screening , 2009, J. Chem. Inf. Model..
[57] Yongbo Hu,et al. Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy , 2009, J. Chem. Inf. Model..
[58] Markus H J Seifert,et al. Targeted scoring functions for virtual screening. , 2009, Drug discovery today.
[59] Thomas A. Halgren,et al. Identifying and Characterizing Binding Sites and Assessing Druggability , 2009, J. Chem. Inf. Model..
[60] Lin He,et al. SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical–protein interactome , 2009, Nucleic Acids Res..
[61] Zhihai Liu,et al. Evaluation of the performance of four molecular docking programs on a diverse set of protein‐ligand complexes , 2010, J. Comput. Chem..
[62] Philippe Chaignon,et al. NADH oxidase activity of Bacillus subtilis nitroreductase NfrA1: Insight into its biological role , 2010, FEBS letters.
[63] David B Jackson,et al. Drug profiling: knowing where it hits. , 2010, Drug discovery today.
[64] Ian T. Crosby,et al. Homology Modeling and Docking Evaluation of Aminergic G Protein-Coupled Receptors , 2010, J. Chem. Inf. Model..
[65] Weihua Li,et al. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening. , 2010, Journal of medicinal chemistry.